Embla Medical hf (OCSE:EMBLA) Cash And Cash Equivalents : kr531 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Cash And Cash Equivalents?

Embla Medical hf's quarterly cash and cash equivalents increased from Sep. 2023 (kr491.63 Mil) to Dec. 2023 (kr496.57 Mil) and increased from Dec. 2023 (kr496.57 Mil) to Mar. 2024 (kr530.66 Mil).

Embla Medical hf's annual cash and cash equivalents declined from Dec. 2021 (kr560.68 Mil) to Dec. 2022 (kr538.17 Mil) and declined from Dec. 2022 (kr538.17 Mil) to Dec. 2023 (kr496.57 Mil).

Embla Medical hf Cash And Cash Equivalents Historical Data

The historical data trend for Embla Medical hf's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Cash And Cash Equivalents Chart

Embla Medical hf Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

394.04

625.99

560.68

538.17

496.57

Embla Medical hf Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial															515.76	489.76	491.63	496.57	530.66

Embla Medical hf Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Embla Medical hf (OCSE:EMBLA) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Embla Medical hf Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Embla Medical hf (OCSE:EMBLA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

OSSFF:USA OSSUY:USA

Address

Grjothals 5, Reykjavik, ISL

Website

https://www.ossur.com

Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines